Cardiovascular risk factor control among diabetic patients attending community-based diabetic care clinics in Italy

被引:17
作者
Colivicchi, Furio
Uguccioni, Massimo
Ragonese, Mauro
Nardozi, Claudio
Angotti, Stefania
Principe, Francesco
Lo Pinto, Sandro
Santini, Massimo
机构
[1] S Filippo Neri Hosp, Cardiovasc Dept, Rome, Italy
[2] CTO Hosp, Div Cardiol, Rome, Italy
[3] ACI SMOM, Daibet Care Clin, Rome, Italy
关键词
diabetes mellitus; cardiovascular risk factors; hypertension; quality of care;
D O I
10.1016/j.diabres.2006.05.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim of this study: To describe the extent to which hyperglycemia, hypertension, and dyslipidemia are currently detected, treated, and controlled in diabetic patients attending a network of urban community-based diabetic care clinics in Italy. Methods: The study population included 1078 consecutive patients with type 2 diabetes mellitus (47% women, mean age 67.6 +/- 9.8 years) visited at eight diabetic care clinics between 1 and 30 of November 2004. Values of glycositated hemoglobin, blood pressure, and cholesterol subfractions, as well as clinical and medication data, were prospectively collected in all cases in a computerized database. Results: Despite a high prevalence of hypertension (66.6%), only 29.6% of patients met the treatment goal of a systolic blood pressure < 130 mmHg, while a diastolic blood pressure < 80 mmHg was reached by 38.6% of the study cohort. Optimal LDL cholesterol values (< 100 mg/dl) were present in just 25.5% of cases. Values of glycosilated hemoglobin < 7% were present in 57.8% of patients. Conclusions: We conclude that adherence to current guidelines for cardiovascular prevention and cardiovascular risk factor control represent an exception in diabetic patients attending community-based diabetic care clinics. Major efforts are required to improve the quality of health care currently delivered to diabetic patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 27 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]  
*AG SAN PUBB REG L, 2005, QUAL ASS DIAB REG IT
[3]  
*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS64
[4]  
[Anonymous], 1982, MINNESOTA CODE RESTI
[5]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[6]  
Collins R, 2003, LANCET, V361, P2005
[7]  
Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87
[8]   Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: The SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study [J].
Comaschi, M ;
Coscelli, C ;
Cucinotta, D ;
Malini, P ;
Manzato, E ;
Nicolucci, A .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (03) :204-211
[9]  
DAI study group, 2001, Ann Ist Super Sanita, V37, P289
[10]  
DEBACKER G, 2003, PREV REHABIL S1, V10, pS1